TBI is a major threat to Soldier readiness and currently lacks any FDA-approved drug treatment options. WRAIR is working to fill this capability gap by developing novel, ground-breaking solutions to mitigate TBI at the point-of-injury to reduce morbidity and mortality in a prolonged field care environment.